A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program - Archive ouverte HAL Access content directly
Journal Articles Current Pharmaceutical Design Year : 2020

A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program

(1) , (1) , (1) , (2) , (2) , (3) , (3) , (3) , (1)
1
2
3

Abstract

Background: Molecular changes associated with the initiation of the epithelial to mesenchymal transition (EMT) program involve alterations of large proteome-based networks. The role of protein products mapping to non-coding genomic regions is still unexplored. Objective: The goal of this study was the identification of an alternative protein signature in breast cancer cellular models with a distinct expression of EMT markers. Methods: We profiled MCF-7 and MDA-MB-231 cells using liquid-chromatography mass/spectrometry (LCMS/ MS) and interrogated the OpenProt database to identify novel predicted isoforms and novel predicted proteins from alternative open reading frames (AltProts). Results: Our analysis revealed an AltProt and isoform protein signature capable of classifying the two breast cancer cell lines. Among the most highly expressed alternative proteins, we observed proteins potentially associated with inflammation, metabolism and EMT. Conclusion: Here, we present an AltProts signature associated with EMT. Further studies will be needed to define their role in cancer progression.
Not file

Dates and versions

inserm-02941785 , version 1 (17-09-2020)

Identifiers

Cite

Daniele Vergara, Tiziano Verri, Marina Damato, Marco Trerotola, Pasquale Simeone, et al.. A Hidden Human Proteome Signature Characterizes the Epithelial Mesenchymal Transition Program. Current Pharmaceutical Design, 2020, 26 (3), pp.372-375. ⟨10.2174/1381612826666200129091610⟩. ⟨inserm-02941785⟩

Collections

INSERM UNIV-LILLE
16 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More